<VariationArchive VariationID="2847831" VariationName="NM_014252.4(SLC25A15):c.776dup (p.Asn259fs)" VariationType="Duplication" Accession="VCV002847831" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-29" DateCreated="2024-02-20" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3008903" VariationID="2847831">
      <GeneList>
        <Gene Symbol="SLC25A15" FullName="solute carrier family 25 member 15" GeneID="10166" HGNC_ID="HGNC:10985" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q14.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="40789611" stop="40812460" display_start="40789611" display_stop="40812460" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="41363546" stop="41386595" display_start="41363546" display_stop="41386595" Strand="+" />
          </Location>
          <OMIM>603861</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_014252.4(SLC25A15):c.776dup (p.Asn259fs)</Name>
      <CanonicalSPDI>NC_000013.11:40808586:AAAAA:AAAAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>13q14.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="40808586" stop="40808587" display_start="40808586" display_stop="40808587" variantLength="1" positionVCF="40808586" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="41382722" stop="41382723" display_start="41382722" display_stop="41382723" variantLength="1" positionVCF="41382722" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
      </Location>
      <ProteinChange>N259fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.41382727dup" Assembly="GRCh37">
            <Expression>NC_000013.10:g.41382727dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.40808591dup" Assembly="GRCh38">
            <Expression>NC_000013.11:g.40808591dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012248.1" sequenceAccession="NG_012248" sequenceVersion="1" change="g.24181dup">
            <Expression>NG_012248.1:g.24181dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014252.4" sequenceAccession="NM_014252" sequenceVersion="4" change="c.776dup" MANESelect="true">
            <Expression>NM_014252.4:c.776dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055067.1" sequenceAccession="NP_055067" sequenceVersion="1" change="p.Asn259fs">
            <Expression>NP_055067.1:p.Asn259fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_014252.4(SLC25A15):c.776dup (p.Asn259fs) AND Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome" Accession="RCV003616722" Version="1">
        <ClassifiedConditionList TraitSetID="1660">
          <ClassifiedCondition DB="MedGen" ID="C0268540">Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-06-23" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-20" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16376511</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23430880</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1660" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5287" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome</ElementValue>
                <XRef ID="Ornithine+translocase+deficiency+syndrome/5413" DB="Genetic Alliance" />
                <XRef ID="30287008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HHH syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ornithine translocase deficiency</ElementValue>
                <XRef ID="MONDO:0009393" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ornithine translocase deficiency syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HHHS</ElementValue>
                <XRef Type="MIM" ID="238970" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HHH</ElementValue>
                <XRef Type="MIM" ID="238970" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome is a disorder of the urea cycle and ornithine degradation pathway. Clinical manifestations and age of onset vary among individuals even in the same family. Neonatal onset (~8% of affected individuals). Manifestations of hyperammonemia usually begin 24-48 hours after feeding begins and can include lethargy, somnolence, refusal to feed, vomiting, tachypnea with respiratory alkalosis, and/or seizures. Infantile, childhood, and adult onset (~92%). Affected individuals may present with: Chronic neurocognitive deficits (including developmental delay, ataxia, spasticity, learning disabilities, cognitive deficits, and/or unexplained seizures); Acute encephalopathy secondary to hyperammonemic crisis precipitated by a variety of factors; and Chronic liver dysfunction (unexplained elevation of liver transaminases with or without mild coagulopathy, with or without mild hyperammonemia and protein intolerance). Neurologic findings and cognitive abilities can continue to deteriorate despite early metabolic control that prevents hyperammonemia.</Attribute>
                <XRef ID="NBK97260" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2830" />
                <XRef ID="2830" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22649802</ID>
                <ID Source="BookShelf">NBK97260</ID>
              </Citation>
              <XRef ID="415" DB="Orphanet" />
              <XRef ID="C0268540" DB="MedGen" />
              <XRef ID="MONDO:0009393" DB="MONDO" />
              <XRef Type="MIM" ID="238970" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8235962" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="19098240|MedGen:C0268540" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004447769" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16376511</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23430880</ID>
          </Citation>
          <Comment>This variant disrupts a region of the SLC25A15 protein in which other variant(s) (p.Arg275*) have been determined to be pathogenic (PMID: 16376511, 23430880; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with SLC25A15-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Asn259Lysfs*2) in the SLC25A15 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 43 amino acid(s) of the SLC25A15 protein. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC25A15" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.41382722_41382723insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268540" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8235962" TraitType="Disease" MappingType="XRef" MappingValue="C0268540" MappingRef="MedGen">
        <MedGen CUI="C0268540" Name="Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

